Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

The lung microbiome after lung transplantation.

Becker J, Poroyko V, Bhorade S.

Expert Rev Respir Med. 2014 Apr;8(2):221-31. doi: 10.1586/17476348.2014.890518. Review.

PMID:
24601662
2.

Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Diamond JM, Akimova T, Kazi A, Shah RJ, Cantu E, Feng R, Levine MH, Kawut SM, Meyer NJ, Lee JC, Hancock WW, Aplenc R, Ware LB, Palmer SM, Bhorade S, Lama VN, Weinacker A, Orens J, Wille K, Crespo M, Lederer DJ, Arcasoy S, Demissie E, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2014 Mar 1;189(5):567-75. doi: 10.1164/rccm.201307-1283OC.

3.

Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.

Shah RJ, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Am J Transplant. 2014 Feb;14(2):446-52. doi: 10.1111/ajt.12541. Epub 2014 Jan 8.

4.

Invited commentary.

Bhorade S.

Ann Thorac Surg. 2014 Jan;97(1):274-5. doi: 10.1016/j.athoracsur.2013.08.034. No abstract available.

PMID:
24384177
5.

A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension.

Patel M, Predescu D, Tandon R, Bardita C, Pogoriler J, Bhorade S, Wang M, Comhair S, Hemnes AR, Chen J, Machado R, Husain A, Erzurum S, Predescu S.

J Biol Chem. 2013 Sep 6;288(36):25701-16. doi: 10.1074/jbc.M113.502674. Epub 2013 Jul 26. Erratum in: J Biol Chem. 2013 Dec 27;288(52):36855. Ryan-Hemnes, Anna [corrected to Hemnes, Anna Ryan].

6.

Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.

Shah RJ, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD.

Chest. 2013 Aug;144(2):616-22. doi: 10.1378/chest.12-1480.

7.

A longitudinal study of patients' symptoms before and during the first year after lung transplantation.

Lanuza DM, Lefaiver CA, Brown R, Muehrer R, Murray M, Yelle M, Bhorade S.

Clin Transplant. 2012 Nov-Dec;26(6):E576-89. doi: 10.1111/ctr.12002. Epub 2012 Sep 18.

8.

SaLUTaRy: survey of lung transplant rejection.

Gordon IO, Bhorade S, Vigneswaran WT, Garrity ER, Husain AN.

J Heart Lung Transplant. 2012 Sep;31(9):972-9. doi: 10.1016/j.healun.2012.05.014.

PMID:
22884384
9.

Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.

Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):546-52. Epub 2012 Jul 19.

10.

A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.

Shah RJ, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD.

J Heart Lung Transplant. 2012 Sep;31(9):942-9. doi: 10.1016/j.healun.2012.05.001. Epub 2012 Jun 12.

11.

Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, Bellamy S, Palmer SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Kohl BA, Deutschman CC, Arcasoy S, Shah AS, Belperio JA, Wilkes D, Reynolds JM, Ware LB, Christie JD; Lung Transplant Outcomes Group.

Am J Transplant. 2011 Nov;11(11):2517-22. doi: 10.1111/j.1600-6143.2011.03702.x. Epub 2011 Aug 22.

12.

Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, Palmer SM, Lee J, Diamond JM, Wille KM, Weinacker A, Lama VN, Crespo M, Orens JB, Sonett JR, Arcasoy SM, Ware LB, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1055-61. doi: 10.1164/rccm.201104-0728OC.

13.

Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.

Sims MW, Beers MF, Ahya VN, Kawut SM, Sims KD, Lederer DJ, Palmer SM, Wille K, Lama VN, Shah PD, Orens JB, Bhorade S, Crespo M, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Chest. 2011 Aug;140(2):489-96. doi: 10.1378/chest.10-2065. Epub 2011 Feb 24.

14.

Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Diamond JM, Kawut SM, Lederer DJ, Ahya VN, Kohl B, Sonett J, Palmer SM, Crespo M, Wille K, Lama VN, Shah PD, Orens J, Bhorade S, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Am J Transplant. 2011 Mar;11(3):561-7. doi: 10.1111/j.1600-6143.2010.03431.x. Epub 2011 Feb 7.

15.

Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.

Ahya VN, McShane PJ, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Garrity E, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Bhorade S.

J Heart Lung Transplant. 2011 Feb;30(2):175-81. doi: 10.1016/j.healun.2010.08.010. Epub 2010 Oct 13.

PMID:
20947384
16.

Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.

Bhorade S, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, Deoliveira NC, Husain A, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Garrity E.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):379-87. doi: 10.1164/rccm.201005-0775OC. Epub 2010 Sep 10.

PMID:
20833822
17.

Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta.

Sandbo N, Kregel S, Taurin S, Bhorade S, Dulin NO.

Am J Respir Cell Mol Biol. 2009 Sep;41(3):332-8. doi: 10.1165/rcmb.2008-0288OC. Epub 2009 Jan 16.

18.

Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome.

Vigneswaran WT, Bhorade S, Wolfe M, Pelletiere K, Garrity ER Jr.

Int Surg. 2007 Mar-Apr;92(2):93-8.

PMID:
17518251
19.

The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide.

Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB.

Am J Respir Crit Care Med. 2000 May;161(5):1443-9.

PMID:
10806137
20.

Response to inhaled nitric oxide in patients with acute right heart syndrome.

Bhorade S, Christenson J, O'connor M, Lavoie A, Pohlman A, Hall JB.

Am J Respir Crit Care Med. 1999 Feb;159(2):571-9.

PMID:
9927375
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk